HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N-octyl-beta-valienamine

structure in first source
Also Known As:
N-octyl-4-epi-beta-valienamine
Networked: 9 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Suzuki, Yoshiyuki: 7 articles (01/2009 - 12/2003)
2. Ogawa, Seiichiro: 6 articles (01/2009 - 12/2003)
3. Ohno, Kousaku: 3 articles (05/2007 - 12/2003)
4. Nanba, Eiji: 3 articles (09/2006 - 12/2003)
5. Higaki, Katsumi: 3 articles (09/2006 - 12/2003)
6. Sawa, Miwa: 2 articles (05/2007 - 08/2004)
7. Ida, Hiroyuki: 2 articles (05/2007 - 08/2004)
8. Ninomiya, Haruaki: 2 articles (05/2007 - 08/2004)
9. Eto, Yoshikatsu: 2 articles (05/2007 - 08/2004)
10. Iida, Masami: 2 articles (05/2007 - 09/2006)

Related Diseases

1. GM1 Gangliosidosis (Gangliosidosis GM1)
2. Mucopolysaccharidosis IV (Morquio Syndrome)
3. Fabry Disease (Fabry's Disease)
4. Gangliosidoses (Gangliosidosis)
5. Gaucher Disease (Gaucher's Disease)

Related Drugs and Biologics

1. Galactose (Galactopyranose)
2. beta-Galactosidase (Lactaid)
3. 1-deoxygalactonojirimycin
4. beta-Glucosidase
5. N-octyl-beta-valienamine
6. Glycolipids
7. valienamine